News

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...
For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...
Duke has lost millions in funding this year as the courts and President Donald Trump clash over the future of the National ...
Now, the NIH will limit the funding of indirect costs to 15%. Indirect costs refer to a large category of operating costs that cover anything from maintenance to personnel wages for support staff.
The NIH has canceled $9.5 billion worth of funding through 2,100 research grants since January and another $2.6 billion in contracts supporting clinical trials, according to a recent letter signed ...
Industry funding along with research productivity were the strongest factors for academic promotion among dermatologists in the United States, whereas NIH grants were not associated with ...
There were 78,354 active grants in the NIH system as of June 17, up from 77,807 the week prior, signaling that new awards are proceeding even as many others are being canceled.
Higher Education NIH resumes, then again pauses funding to Columbia amid negotiations Researchers at the Ivy League university got word Wednesday that the three-month funding pause was lifted, but ...
In a ruling issued Monday, the judge called the government’s directives “arbitrary and capricious” and ordered funding for some of the NIH grants, including many profiled by ProPublica in ...
Below is a state-by-state breakdown of NIH grant funding losses, offering a snapshot of where grant terminations are being felt the most. Massachusetts — $1,274,165,191 New York — $487,367,224 ...
Since President Donald Trump's inauguration, the NIH has ended 2,100 research grants worth around $9.5 billion and contracts worth $2.6 billion, the authors wrote in the June 9 Bethesda Declaration.
The letter speaks out against moves by the NIH to terminate 2,100 research grants totaling $9.5 billion, plus an additional $2.6 billion in contracts, since President Donald Trump took office Jan. 20.